• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.物质使用障碍对美国 2 年内艾滋病病毒护理保留的影响。
AIDS Behav. 2018 Mar;22(3):742-751. doi: 10.1007/s10461-017-1826-2.
2
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.美国接受艾滋病护理的人群中物质使用障碍的患病率及预测因素
AIDS Behav. 2017 Apr;21(4):1138-1148. doi: 10.1007/s10461-016-1584-6.
3
Low levels of initiation, engagement, and retention in substance use disorder treatment including pharmacotherapy among HIV-infected and uninfected veterans.在感染和未感染 HIV 的退伍军人中,物质使用障碍治疗(包括药物治疗)的开始、参与和维持率都很低。
J Subst Abuse Treat. 2019 Aug;103:23-32. doi: 10.1016/j.jsat.2019.05.007. Epub 2019 May 7.
4
Social determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada.加拿大安大略省一个临床队列中健康的社会决定因素与艾滋病护理留存率
AIDS Care. 2017 Jul;29(7):828-837. doi: 10.1080/09540121.2016.1271389. Epub 2016 Dec 27.
5
HIV Linkage to Care and Retention in Care Rate Among MSM in Guangzhou, China.中国广州男男性行为者中 HIV 衔接护理和护理保留率。
AIDS Behav. 2018 Mar;22(3):701-710. doi: 10.1007/s10461-017-1893-4.
6
Predictors for Poor Linkage to Care Among Hospitalized Persons Living with HIV and Co-Occurring Substance Use Disorder.住院的 HIV 合并物质使用障碍患者与护理衔接不良的预测因素。
AIDS Res Hum Retroviruses. 2020 May;36(5):406-414. doi: 10.1089/AID.2019.0153. Epub 2020 Mar 3.
7
Potential Influences of the COVID-19 Pandemic on Drug Use and HIV Care Among People Living with HIV and Substance Use Disorders: Experience from a Pilot mHealth Intervention.新冠疫情对 HIV 感染者和物质使用障碍患者的药物使用和 HIV 护理的潜在影响:一项移动医疗干预试点的经验。
AIDS Behav. 2021 Feb;25(2):354-359. doi: 10.1007/s10461-020-02976-1.
8
Substance abuse and HIV infection.药物滥用与艾滋病毒感染。
Top HIV Med. 2003 Jan-Feb;11(1):20-4.
9
Integrated Care on Leaving Hospital Against Medical Advice Among HIV-Infected People with Substance Use Disorders.针对患有物质使用障碍的艾滋病毒感染者违反医疗建议出院后的综合护理。
AIDS Res Hum Retroviruses. 2018 Dec;34(12):1044-1049. doi: 10.1089/AID.2018.0087. Epub 2018 Sep 11.
10
Association Between Diagnoses of Chronic Noncancer Pain, Substance Use Disorder, and HIV-Related Outcomes in People Living With HIV.慢性非癌性疼痛诊断、物质使用障碍与HIV感染者的HIV相关结局之间的关联
J Acquir Immune Defic Syndr. 2019 Dec 1;82 Suppl 2(2):S142-S147. doi: 10.1097/QAI.0000000000002179.

引用本文的文献

1
Health System-Level Implementation of Digital Health Support for People Living With HIV and Substance Use Disorders: Protocol for a Cluster-Randomized, Stepped-Wedge Clinical Trial.为感染艾滋病毒和患有物质使用障碍的人群提供数字健康支持的卫生系统层面实施:一项整群随机、阶梯式楔形临床试验方案。
JMIR Res Protoc. 2025 Aug 29;14:e69842. doi: 10.2196/69842.
2
Associations Between Healthcare Providers' Stigmatizing Attitudes Toward People Living with HIV and People Who Use Drugs: A Canonical Correlation Analysis.医疗服务提供者对艾滋病毒感染者和吸毒者的污名化态度之间的关联:典型相关分析
AIDS Behav. 2025 Jun 16. doi: 10.1007/s10461-025-04794-9.
3
"Let me hear what you're needing": exploring how HIV providers conceptualize patient-provider interactions with people with HIV who use drugs using a harm reduction framework.“告诉我你需要什么”:运用减少伤害框架,探索艾滋病病毒感染者护理人员如何理解与吸毒的艾滋病病毒感染者之间的医患互动。
Ther Adv Infect Dis. 2025 Feb 27;12:20499361251323721. doi: 10.1177/20499361251323721. eCollection 2025 Jan-Dec.
4
Week 96 Results of Bictegravir/Emtricitabine/Tenofovir Alafenamide for HIV Treatment in People With Substance Use Disorders.第96周 比克替拉韦/恩曲他滨/丙酚替诺福韦用于治疗物质使用障碍患者的HIV的结果
Open Forum Infect Dis. 2024 Dec 20;12(1):ofae737. doi: 10.1093/ofid/ofae737. eCollection 2025 Jan.
5
Association between substance use disorders and sustained viral suppression: a longitudinal analysis among people with HIV in South Carolina.物质使用障碍与病毒持续抑制之间的关联:南卡罗来纳州HIV感染者的纵向分析。
AIDS. 2025 Apr 1;39(5):560-568. doi: 10.1097/QAD.0000000000004077. Epub 2024 Nov 27.
6
Cannabis use patterns among people with HIV before and after legalization.大麻合法化前后艾滋病毒感染者的大麻使用模式。
Drug Alcohol Depend Rep. 2024 Oct 28;13:100291. doi: 10.1016/j.dadr.2024.100291. eCollection 2024 Dec.
7
Implementation of Injectable Cabotegravir/Rilpivirine for Treatment of Human Immunodeficiency Virus in Patients With Substance Use Disorders at a Syringe Exchange Clinic.在一家注射器交换诊所,使用注射用卡博特韦/利匹韦林治疗患有物质使用障碍的人类免疫缺陷病毒感染者。
Open Forum Infect Dis. 2024 Oct 23;11(11):ofae640. doi: 10.1093/ofid/ofae640. eCollection 2024 Nov.
8
Cohort profile update: the Johns Hopkins HIV clinical cohort, 1989-2023.队列资料更新:约翰霍普金斯艾滋病毒临床队列,1989-2023 年。
Eur J Epidemiol. 2024 Sep;39(9):1051-1062. doi: 10.1007/s10654-024-01147-z. Epub 2024 Sep 18.
9
HIV status and substance use disorder treatment need and utilization among adults in the United States, 2015-2019: Implications for healthcare service provision and integration.2015-2019 年美国成年人的 HIV 状况和物质使用障碍治疗需求与利用:对医疗保健服务提供和整合的影响。
J Subst Use Addict Treat. 2024 Sep;164:209440. doi: 10.1016/j.josat.2024.209440. Epub 2024 Jun 14.
10
Use of machine learning approaches to predict transition of retention in care among people living with HIV in South Carolina: a real-world data study.利用机器学习方法预测南卡罗来纳州 HIV 感染者的护理保留情况转变:一项真实世界数据研究。
AIDS Care. 2024 Dec;36(12):1745-1753. doi: 10.1080/09540121.2024.2361245. Epub 2024 Jun 4.

本文引用的文献

1
Prevalence and Predictors of Substance Use Disorders Among HIV Care Enrollees in the United States.美国接受艾滋病护理的人群中物质使用障碍的患病率及预测因素
AIDS Behav. 2017 Apr;21(4):1138-1148. doi: 10.1007/s10461-016-1584-6.
2
Poverty matters: contextualizing the syndemic condition of psychological factors and newly diagnosed HIV infection in the United States.贫困问题:将心理因素与美国新诊断出的艾滋病毒感染的综合征状况置于具体情境中考量。
AIDS. 2014 Nov 28;28(18):2763-9. doi: 10.1097/QAD.0000000000000491.
3
The efficacy of case management with persons who have substance abuse problems: a three-level meta-analysis of outcomes.针对有药物滥用问题者的个案管理效果:结局的三级荟萃分析
J Consult Clin Psychol. 2014 Aug;82(4):605-18. doi: 10.1037/a0036750. Epub 2014 May 12.
4
The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS.大麻在医学上用于降低艾滋病毒/艾滋病患者的发病率和死亡率。
Cochrane Database Syst Rev. 2013 Apr 30(4):CD005175. doi: 10.1002/14651858.CD005175.pub3.
5
High levels of antiretroviral use and viral suppression among persons in HIV care in the United States, 2010.2010 年美国接受艾滋病毒护理人群中抗逆转录病毒药物的使用和病毒抑制水平较高。
J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):299-306. doi: 10.1097/QAI.0b013e3182945bc7.
6
HIV transmission in the United States: considerations of viral load, risk behavior, and health disparities.美国的 HIV 传播:病毒载量、风险行为和健康差异的考虑因素。
AIDS Behav. 2013 Jun;17(5):1632-6. doi: 10.1007/s10461-013-0426-z.
7
Retention among North American HIV-infected persons in clinical care, 2000-2008.2000-2008 年北美感染艾滋病毒人群在临床护理中的保留率。
J Acquir Immune Defic Syndr. 2013 Mar 1;62(3):356-62. doi: 10.1097/QAI.0b013e31827f578a.
8
Cannabis use and HIV antiretroviral therapy adherence and HIV-related symptoms.大麻使用与 HIV 抗逆转录病毒治疗依从性和 HIV 相关症状。
J Behav Med. 2014 Feb;37(1):1-10. doi: 10.1007/s10865-012-9458-5. Epub 2012 Oct 7.
9
Measuring retention in HIV care: the elusive gold standard.评估艾滋病护理中的患者保留率:难以捉摸的金标准。
J Acquir Immune Defic Syndr. 2012 Dec 15;61(5):574-80. doi: 10.1097/QAI.0b013e318273762f.
10
Comparative performance of the AUDIT-C in screening for DSM-IV and DSM-5 alcohol use disorders.AUDIT-C 量表筛查 DSM-IV 和 DSM-5 酒精使用障碍的比较效能。
Drug Alcohol Depend. 2012 Dec 1;126(3):384-8. doi: 10.1016/j.drugalcdep.2012.05.029. Epub 2012 Jun 22.

物质使用障碍对美国 2 年内艾滋病病毒护理保留的影响。

Influence of Substance Use Disorders on 2-Year HIV Care Retention in the United States.

机构信息

Alcohol & Drug Abuse Institute, University of Washington, 1107 NE 45th Street Suite 120, Box 354805, Seattle, WA, 98105-4631, USA.

Division of Allergy and Infectious Disease, University of Washington, Seattle, WA, USA.

出版信息

AIDS Behav. 2018 Mar;22(3):742-751. doi: 10.1007/s10461-017-1826-2.

DOI:10.1007/s10461-017-1826-2
PMID:28612213
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5729068/
Abstract

Substance use disorders (SUDs) are thought to predict care discontinuity, though magnitude and substance-specific variance of effects are unclear. This report of analytic work undertaken with a multi-regional American cohort of 9153 care enrollees addresses these gaps. Care retention was computed from 24-month post-linkage clinic visit documentation, with SUD cases identified from patient-report screening instruments. Two generalized estimating equations tested binary and hierarchial SUD predictors of retention, and potential effect modification by patient age-group, sex, and care site. Findings demonstrate: (1) detrimental SUD effect, equivalent to a nine percentage-point decrease in retention, with independent effects of age-group and care site; (2) substance-specific effect of marijuana UD associated with lower retention; and (3) age-modification of each effect on care discontinuity, with SUDs serving as a risk factor among 18-29 year-olds and protective factor among 60+ year-olds. Collective findings document patient attributes as influences that place particular subgroups at-risk to discontinue care.

摘要

物质使用障碍(SUD)被认为可预测治疗中断,但影响的幅度和物质特异性尚不清楚。本报告分析了来自美国多地区队列的 9153 名治疗参与者的资料,旨在解决这些差距。通过链接后的诊所就诊记录计算了治疗保留率,通过患者报告筛查工具确定了 SUD 病例。采用两种广义估计方程检验了保留率的二项和分层 SUD 预测因素,以及患者年龄组、性别和治疗地点的潜在调节作用。研究结果表明:(1)SUD 对治疗保留率有不利影响,相当于保留率降低了 9 个百分点,且受年龄组和治疗地点的独立影响;(2)与大麻使用障碍相关的物质特异性对保留率有影响;(3)每种效应在治疗中断方面的年龄修饰作用,SUD 在 18-29 岁人群中是一个风险因素,在 60 岁以上人群中是一个保护因素。总的来说,这些发现证明了患者属性是影响特定亚组人群停止治疗的因素。